Department of Cardiovascular Surgery, Tianjin First Center Hospital and NanKai University, Tianjin, China.
Department of Cardiovascular Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, China.
J Cardiothorac Surg. 2020 Oct 7;15(1):302. doi: 10.1186/s13019-020-01351-4.
This study aimed to identify the incidence rate of Acute kidney injury (AKI) in our center and predict in-hospital mortality and long-term survival after heart transplantation (HTx).
This single-center, retrospective study from October 2009 and March 2020 analyzed the pre-, intra-, and postoperative characteristics of 95 patients who underwent HTx. AKI was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Risk factors were analyzed by multivariable logistic regression models. The log-rank test was used to compare long-term survival.
Thirty-three (34.7%) patients developed AKI. The mortality in hospital in HTx patients with and without AKI were 21.21 and 6.45%, respectively (P < 0.05). Recipients in AKI who required renal replacement therapy (RRT) had a hospital mortality rate of 43.75% compared to 6.45% in those without AKI or RRT (P < 0.0001). A long cardiopulmonary bypass (CPB) time (OR:11.393, 95% CI: 2.183 to 59.465, P = 0.0039) was positively related to the occurrence of AKI. A high intraoperative urine volume (OR: 0.031, 95% CI: 0.005 to 0.212, P = 0.0004) was negatively correlated with AKI. AKI requiring RRT (OR, 11.348; 95% CI, 2.418-53.267, P = 0.002) was a risk factor for mortality in hospital. Overall survival in patients without AKI at 1 and 3 years was not different from that in patients with AKI (P = 0.096).
AKI is common after HTx. AKI requiring RRT could contribute powerful prognostic information to predict mortality in hospital. A long CPB time and low intraoperative urine volume are associated with the occurrence of AKI.
本研究旨在确定我们中心急性肾损伤(AKI)的发生率,并预测心脏移植(HTx)后的院内死亡率和长期生存率。
这是一项 2009 年 10 月至 2020 年 3 月进行的单中心回顾性研究,分析了 95 例接受 HTx 的患者的术前、术中和术后特征。AKI 根据肾脏病:改善全球结局(KDIGO)标准定义。多变量逻辑回归模型分析危险因素。对数秩检验用于比较长期生存率。
33 例(34.7%)患者发生 AKI。HTx 患者 AKI 组和无 AKI 组的院内死亡率分别为 21.21%和 6.45%(P<0.05)。需要肾脏替代治疗(RRT)的 AKI 患者的院内死亡率为 43.75%,而无 AKI 或 RRT 的患者为 6.45%(P<0.0001)。较长的体外循环(CPB)时间(OR:11.393,95%CI:2.183 至 59.465,P=0.0039)与 AKI 的发生呈正相关。术中尿量较高(OR:0.031,95%CI:0.005 至 0.212,P=0.0004)与 AKI 呈负相关。需要 RRT 的 AKI(OR,11.348;95%CI,2.418-53.267,P=0.002)是院内死亡的危险因素。无 AKI 患者在 1 年和 3 年的总生存率与 AKI 患者无差异(P=0.096)。
AKI 在 HTx 后很常见。需要 RRT 的 AKI 可提供有力的预后信息,预测院内死亡率。较长的 CPB 时间和较低的术中尿量与 AKI 的发生相关。